Schedule 13D ownership disclosure

REPLICEL LIFE SCIENCES INC.

Security class unavailable · CUSIP: 76027P400

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
18,624,006
Percent of class
31.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085037-23-000014
Form type
SC 13D/A
Filer
REPLICEL LIFE SCIENCES INC.
CIK
CIK 1205059
Filed
Jan 26, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub